medical device investing ChroMedX Strengthens Board of Directors with the Appointment of Dr. Richard Janeczko
Genetic Technologies and the University of Melbourne Sign License Agreement to Develop Colorectal Cancer Test
EraNova Announces Positive Preliminary Economic Assessment for the Adanac Molybdenum Project: After-Tax NPV of $714.4 Million and 23.5% IRR
